Roche Diagnostics Corporation v. Dickstein

CourtDistrict Court, E.D. Michigan
DecidedMarch 1, 2024
Docket2:19-cv-10264
StatusUnknown

This text of Roche Diagnostics Corporation v. Dickstein (Roche Diagnostics Corporation v. Dickstein) is published on Counsel Stack Legal Research, covering District Court, E.D. Michigan primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Roche Diagnostics Corporation v. Dickstein, (E.D. Mich. 2024).

Opinion

UNITED STATES DISTRICT COURT EASTERN DISTRICT OF MICHIGAN SOUTHERN DIVISION

ROCHE DIAGNOSTICS CORP. and ROCHE DIABETES CARE, INC., Case No. 19-10264 Plaintiffs, Paul D. Borman v. United States District Judge

CHRISTOPHER F. SHAYA,

Defendant, _________________________________/

OPINION AND ORDER DENYING DEFENDANT CHRISTOPHER SHAYA’S MOTION FOR RECONSIDERATION OF NOVEMBER 9, 2023 OPINION AND ORDER GRANTING PLAINTIFFS’ MOTION IN LIMINE TO PRECLUDE EVIDENCE OR ARGUMENT REGARDING MANUFACTURING COSTS OR PROFIT MARGINS (ECF NO. 186)

I. INTRODUCTION This case involves an alleged scheme by Defendant Christopher Shaya to use his companies, Olympus Global, LLC (Olympus) and Delta Global, LLC (Delta), to purchase not-for-retail-sale (NFR) diabetes test strips manufactured by Plaintiffs Roche Diagnostics Corp. and Roche Diabetes Care, Inc. (together, Roche) from Northwood, Inc. (Northwood), and then resell them in retail markets thereby receiving a significant markup in a sale. (See generally, ECF No. 1, Complaint.) Roche asserts claims against Shaya for fraud, unjust enrichment, and tortious interference with contract. (Id.) Roche alleges that Shaya made approximately $8 million “from his fraudulent diversion scheme,” and that Roche has lost more than $80 million in profits (Id.)

On November 9, 2023, this Court entered an Opinion and Order Granting Plaintiffs’ Motion in Limine to Preclude Evidence or Argument Regarding Manufacturing Costs or Profit Margins. (ECF No. 185.)

Now before the Court is Defendant Christopher Shaya’s Motion for Reconsideration of that November 9, 2023 Opinion and Order Granting Plaintiffs’ Motion in Limine to Preclude Evidence or Argument Regarding Manufacturing Costs or Profit Margins (ECF No. 186). The motion for reconsideration has been

fully briefed. (ECF Nos. 188, 189.) Because the Court does not believe that oral argument will aid in its disposition of this motion, it is dispensing with oral argument pursuant to Eastern District of Michigan Local Rule 7.1(f)(1).

For the reasons set forth below, the Court denies Defendants’ motion for reconsideration because it fails to clear the high bar for granting reconsideration in E.D. Mich. L.R. 7.1(h)(2). II. STANDARD OF REVIEW

Eastern District of Michigan Local Rule 7.1 allows a party to file a motion for reconsideration of non-final orders, such as the Opinion and Order at issue in this case. E.D. Mich. L.R. § 7.1(h)(2). That Local Rule provides that “[m]otions for reconsideration of non-final orders are disfavored” and “may be brought only upon the following grounds:

(A) The court made a mistake, correcting the mistake changes the outcome of the prior decision, and the mistake was based on the record and law before the court at the time of its prior decision; (B) An intervening change in controlling law warrants a different outcome; or (C) New facts warrant a different outcome and the new facts could not have been discovered with reasonable diligence before the prior decision.” E.D. Mich. L.R. 7.1(h)(2). “A motion for reconsideration is not intended as a means to allow a losing party simply to rehash rejected arguments or to introduce new arguments.” Southfield Educ. Ass’n v. Bd. of Educ. of Southfield Pub. Schs., 319 F. Supp. 3d 898, 901 (E.D. Mich. 2018). Accordingly, a motion for reconsideration which presents the same issues already ruled upon by the court, either expressly or by reasonable implication, will not be granted. Ford Motor Co. v. Greatdomains.com, Inc., 177 F. Supp. 2d 628, 632 (E.D. Mich. 2001). III. ANALYSIS

In his motion for reconsideration, Defendant Shaya has not introduced an intervening change in controlling law or previously undiscoverable facts. He instead argues that his motion for reconsideration is based on his assertion that (1) the court

made a mistake, (2) that correcting the mistake changes the outcome of the prior decision, and (3) that the mistake was based on the records and law before the Court at the time of its prior decision.

Shaya contends that this Court erroneously “ignore[d] the arguments Shaya has made throughout the case” that Roche’s expert’s assumptions are unsupported and should be rejected. (ECF No. 186, Def. Mot., PageID.4952-53.) However, the

Court has not ignored Shaya’s arguments. Rather, Shaya is merely repeating arguments he has made before to this Court, both in his motion to strike Roche’s expert, Dr. Gregory Bell, and in his response to Roche’s motion in limine. The Court has previously thoughtfully considered Shaya’s arguments and found that the

expert’s assumptions find sufficient support in the record, and that Shaya’s challenges to the factual bases of the expert’s testimony concern the weight, rather than the admissibility of that testimony. (See ECF No. 97; ECF No. 185.) As stated

above, motions for reconsideration are not a vehicle “to rehash rejected arguments[,]” see Southfield Educ. Ass’n, 319 F. Supp. 3d at 901, and that is all Shaya is doing here. See Fischer v. United States, 589 F. Supp. 3d 726, 728 (E.D. Mich. 2022) (“A motion for reconsideration that merely reasserts the same facts and

legal arguments previously asserted is not proper unless there was some defect in the first hearing by which the court and the parties have been misled.”) (collecting cases). Shaya argues that the Court’s ruling on Roche’s motion in limine “substantially limits Shaya’s cross-examination of Plaintiffs’ expert and Plaintiffs’

other witnesses, effectively precluding Shaya from presenting any damage defense through Plaintiffs’ witnesses” “that Plaintiffs made a profit on the transactions at issue.” (ECF No. 186, Def. Mot., PageID.4955.)

However, that argument fails. As the Court noted in its November 9, 2023 Opinion and Order, “Roche has never argued that it does not make a profit on the sale of its NFR test strips,” such as the NFR test strips Roche sold to Northwood in this case. (ECF No. 185, Opinion and Order, PageID.4927.) In fact, Roche’s expert,

Dr. Bell, expressly recognized that Roche made a profit on the sale of the NFR test strips to Northwood in this case, opining in his report that “the appropriate measure of Roche’s economic damages with regard to each diverted unit is the difference

between the profit Roche would have earned from the sale of a unit of Retail Strips and the profit Roche actually did earn from its sale of a unit of [NFR] Strips to Northwood.” (ECF No. 87-3, Bell Report, PageID.2296 (emphases added).) Thus, Shaya would be allowed to elicit testimony upon cross-examination of Dr. Bell that

Roche did make a profit from the sale of the NFR test strips to Northwood. However, the amount of that profit and the cost of manufacturing the test strips are not relevant to Roche’s claim for damages in this case. Roche does not argue in

this case that it made no profit from the initial sale of the NFR test strips to Northwood and that it seeks to recover that figure as damages. Roche instead argues that because each sale of a diverted unit of NFR strips displaced what otherwise

would have been the sale of a higher-priced Retail test strip, and because the manufacturing costs of NFR and Retail test strips are the same (a fact Shaya does not challenge), the appropriate measure of Roche’s claimed economic damages in

this case is the difference between the higher wholesale price Roche alleges it would have received for the sale of the Retail strips and the price Roche actually did receive for the NFR strips sold to Northwood, multiplied by the number of diverted units. (See ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Roche Diagnostics Corporation v. Dickstein, Counsel Stack Legal Research, https://law.counselstack.com/opinion/roche-diagnostics-corporation-v-dickstein-mied-2024.